flurbiprofen has been researched along with Anterior Choroidal Artery Infarction in 2 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A multicentre controlled trial was conducted on 383 patients to compare the effectiveness of flurbiprofen (100 mg/day) and an ergot derivative in preventing cerebral infarction." | 9.05 | [Secondary prevention of cerebral infarction caused by atherosclerosis. 3-year comparison of flurbiprofen and an ergot derivative]. ( Dehen, H; Dordain, G; Doyon, F, 1984) |
| "A multicentre controlled trial was conducted on 383 patients to compare the effectiveness of flurbiprofen (100 mg/day) and an ergot derivative in preventing cerebral infarction." | 5.05 | [Secondary prevention of cerebral infarction caused by atherosclerosis. 3-year comparison of flurbiprofen and an ergot derivative]. ( Dehen, H; Dordain, G; Doyon, F, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dehen, H | 2 |
| Dordain, G | 1 |
| Doyon, F | 1 |
2 trials available for flurbiprofen and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
[Controlled trial of flurbiprofen (platelet anti-aggregant) in the secondary prevention of atherosclerotic cerebral infarcts].
Topics: Aged; Arteriosclerosis; Cerebral Infarction; Clinical Trials as Topic; Female; Flurbiprofen; Humans; | 1983 |
[Secondary prevention of cerebral infarction caused by atherosclerosis. 3-year comparison of flurbiprofen and an ergot derivative].
Topics: Arteriosclerosis; Cerebral Infarction; Clinical Trials as Topic; Ergot Alkaloids; Female; Flurbiprof | 1984 |